NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103,590 | -14.0% | 2,341 | -5.4% | 0.00% | – |
Q2 2023 | $120,433 | -15.2% | 2,475 | -3.2% | 0.00% | – |
Q1 2023 | $142,020 | +28.9% | 2,558 | -6.7% | 0.00% | – |
Q4 2022 | $110,186 | -3.3% | 2,743 | +5.7% | 0.00% | – |
Q3 2022 | $114,000 | +37.3% | 2,595 | +11.2% | 0.00% | – |
Q2 2022 | $83,000 | 0.0% | 2,334 | +13.9% | 0.00% | – |
Q1 2022 | $83,000 | +36.1% | 2,049 | +215.2% | 0.00% | – |
Q4 2021 | $61,000 | -28.2% | 650 | -14.4% | 0.00% | – |
Q3 2021 | $85,000 | +4.9% | 759 | +7.5% | 0.00% | – |
Q2 2021 | $81,000 | +285.7% | 706 | +239.4% | 0.00% | – |
Q1 2021 | $21,000 | +75.0% | 208 | +80.9% | 0.00% | – |
Q4 2020 | $12,000 | +140.0% | 115 | +55.4% | 0.00% | – |
Q3 2020 | $5,000 | +66.7% | 74 | +10.4% | 0.00% | – |
Q2 2020 | $3,000 | – | 67 | +2133.3% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 3 | -99.9% | 0.00% | – |
Q4 2019 | $76,000 | -96.9% | 2,257 | -96.9% | 0.00% | -100.0% |
Q3 2019 | $2,425,000 | -16.5% | 73,909 | -29.8% | 0.00% | -33.3% |
Q2 2019 | $2,904,000 | – | 105,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |